CrossrefInfokarte
Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · 412-416
DOI: 10.3816/clm.2009.n.082 ↗Abstract
Kein Abstract verfügbar.
EUVIMED